315 related articles for article (PubMed ID: 31806419)
21. Integration of Hippo-YAP Signaling with Metabolism.
Ibar C; Irvine KD
Dev Cell; 2020 Jul; 54(2):256-267. PubMed ID: 32693058
[TBL] [Abstract][Full Text] [Related]
22. The regulation of Yorkie, YAP and TAZ: new insights into the Hippo pathway.
Manning SA; Kroeger B; Harvey KF
Development; 2020 Apr; 147(8):. PubMed ID: 32341025
[TBL] [Abstract][Full Text] [Related]
23. The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin.
Rognoni E; Walko G
Cells; 2019 May; 8(5):. PubMed ID: 31058846
[TBL] [Abstract][Full Text] [Related]
24. Role of the transcriptional coactivators YAP/TAZ in liver cancer.
Zhang S; Zhou D
Curr Opin Cell Biol; 2019 Dec; 61():64-71. PubMed ID: 31387016
[TBL] [Abstract][Full Text] [Related]
25. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
[TBL] [Abstract][Full Text] [Related]
26. Role of the Hippo Pathway in Fibrosis and Cancer.
Kim CL; Choi SH; Mo JS
Cells; 2019 May; 8(5):. PubMed ID: 31100975
[TBL] [Abstract][Full Text] [Related]
27. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
[TBL] [Abstract][Full Text] [Related]
28. Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.
Ferraiuolo M; Verduci L; Blandino G; Strano S
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467351
[TBL] [Abstract][Full Text] [Related]
29. The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.
Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Sperduti I; Shaaban AM; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
Oncotarget; 2016 Jul; 7(28):43188-43198. PubMed ID: 27248471
[TBL] [Abstract][Full Text] [Related]
30. The novel role of Hippo-YAP/TAZ in immunity at the mammalian maternal-fetal interface: Opportunities, challenges.
Huang Z; Zhou J; Leung WT; Gober HJ; Pan X; Li C; Li L; Wang L
Biomed Pharmacother; 2020 Jun; 126():110061. PubMed ID: 32145593
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma.
Bouvier C; Macagno N; Nguyen Q; Loundou A; Jiguet-Jiglaire C; Gentet JC; Jouve JL; Rochwerger A; Mattei JC; Bouvard D; Salas S
Oncotarget; 2016 Oct; 7(40):64702-64710. PubMed ID: 27608849
[TBL] [Abstract][Full Text] [Related]
32. Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway.
Ehmer U; Sage J
Mol Cancer Res; 2016 Feb; 14(2):127-40. PubMed ID: 26432795
[TBL] [Abstract][Full Text] [Related]
33. Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway.
Chakraborty S; Njah K; Pobbati AV; Lim YB; Raju A; Lakshmanan M; Tergaonkar V; Lim CT; Hong W
Cell Rep; 2017 Mar; 18(10):2464-2479. PubMed ID: 28273460
[TBL] [Abstract][Full Text] [Related]
34. The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling.
Hillmer RE; Link BA
Cells; 2019 May; 8(5):. PubMed ID: 31137701
[TBL] [Abstract][Full Text] [Related]
35. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.].
Ishihara E; Nishina H
Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187
[TBL] [Abstract][Full Text] [Related]
36. The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.
Santucci M; Vignudelli T; Ferrari S; Mor M; Scalvini L; Bolognesi ML; Uliassi E; Costi MP
J Med Chem; 2015 Jun; 58(12):4857-73. PubMed ID: 25719868
[TBL] [Abstract][Full Text] [Related]
37. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
38. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K
Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487
[TBL] [Abstract][Full Text] [Related]
39. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
40. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]